Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mikhail A. Godkov"'
Autor:
Ilya A. Potemkin, Karen K. Kyuregyan, Anastasia A. Karlsen, Olga V. Isaeva, Vera S. Kichatova, Maria A. Lopatukhina, Fedor A. Asadi Mobarkhan, Anna G. Zlobina, Andrey V. Zheltobriukh, Ksenia A. Bocharova, Vera V. Belyakova, Svetlana V. Rassolova, Nadezhda V. Ivanova, Sergey A. Solonin, Alexey I. Bazhenov, Mikhail A. Godkov, Mikhail I. Mikhailov
Publikováno v:
Viruses, Vol 16, Iss 4, p 526 (2024)
Transfusion-transmitted hepatitis E virus (HEV) infection is an increasing concern in many countries. We investigated the detection rate of HEV viremia in blood donors in Russia. A total of 20,405 regular repetitive voluntary non-renumerated blood do
Externí odkaz:
https://doaj.org/article/7fbaf5178abc4ed1b5a3445ed5caa738
Autor:
Mikhail A. Godkov, Darya A. Ogarkova, Vladimir A. Gushchin, Denis A. Kleymenov, Elena P. Mazunina, Evgeniia N. Bykonia, Andrei A. Pochtovyi, Valeriy V. Shustov, Dmitry V. Shcheblyakov, Andrey G. Komarov, Alexander N. Tsibin, Vladimir I. Zlobin, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Vaccines, Vol 11, Iss 1, p 90 (2022)
Vaccination against COVID-19 has occurred in Russia for more than two years. According to the Russian official clinical guidelines to maintain tense immunity in the conditions of the ongoing COVID-19 pandemic, it is necessary to use booster immunizat
Externí odkaz:
https://doaj.org/article/24196fb0741d46f78a08974530fb47c5
Autor:
Vera S. Kichatova, Fedor A. Asadi Mobarkhan, Ilya A. Potemkin, Sergey P. Zlobin, Oksana M. Perfilieva, Vladimir T. Valuev-Elliston, Alexander V. Ivanov, Sergey A. Solonin, Mikhail A. Godkov, Maria G. Belikova, Mikhail I. Mikhailov, Karen K. Kyuregyan
Publikováno v:
Microorganisms, Vol 10, Iss 2, p 429 (2022)
Anti-SARS-CoV-2 antibody testing is an efficient tool to assess the proportion of seropositive population due to infection and/or vaccination. Numerous test systems utilizing various antigen composition(s) are routinely used for detection and quantit
Externí odkaz:
https://doaj.org/article/792882424010444eb45dc37e1f582ce6
Autor:
Mikhail M. Minashkin, Nataliya Y. Grigortsevich, Anna S. Kamaeva, Valeriya V. Barzanova, Alexey A. Traspov, Mikhail A. Godkov, Farkhad A. Ageev, Sergey S. Petrikov, Nataliya V. Pozdnyakova
Publikováno v:
Biomedicines, Vol 10, Iss 3, p 549 (2022)
The aim of this study was to identify single nucleotide variants in genes associated with susceptibility to or severe outcomes of COVID-19. A total of 319 genomic DNA samples from patients with varying degrees of disease severity and 78 control DNA s
Externí odkaz:
https://doaj.org/article/6940b27d4b0a41b69e584305da6788eb
Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma
Autor:
Stanislav Volkov, Andrey Y. Bulanov, S.S. Petrikov, Elena A. Ladygina, Inna V. Dolzhikova, Maria N. Lundgren, Dmitry V. Shcheblyakov, Alexander I. Kostin, Vladimir V. Ganchin, Natalia V. Borovkova, Mikhail A. Godkov, Nataliya E. Drozdova, Eugene A. Dombrovskiy, Alexander L. Gintsburg, Alina R. Kamalova, Karina S. Chirkova, Alexey I. Bazhenov, Alina S. Bogdanova, Valeriy V. Shustov, Denis Y. Logunov
Publikováno v:
Vox Sanguinis
Background and ObjectivesCOVID-19 convalescent plasma is an experimental treatment against SARS-CoV-2. The aim of this study is to assess the impact of different pathogen reduction methods on the levels and virus neutralizing activity of the specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b776f48725065701f8fa73eb9120cd
https://pubmed.ncbi.nlm.nih.gov/33734455
https://pubmed.ncbi.nlm.nih.gov/33734455